Status:
COMPLETED
OptiMoM Grows Up: 5.5-year Follow-up of the OptiMoM Fortifier Study
Lead Sponsor:
The Hospital for Sick Children
Collaborating Sponsors:
Sinai Health System
University of Toronto
Conditions:
Infant, Very Low Birth Weight
Eligibility:
All Genders
5-6 years
Brief Summary
In Canada, the leading cause of long-term disability in children is being born at very low birth weight (VLBW). To help improve outcomes, nutrition is a modifiable aspect of infant care. Mother's milk...
Eligibility Criteria
Inclusion
- Children who were enrolled in the Bovine vs. Human Milk-Based Fortifier Study (NCT02137473)
- Children who were born \>=37 weeks gestation and weighing \> 2500g \[Term-born comparison group\]
Exclusion
- For term-born comparison only: a child with any chromosomal or congenital anomaly affecting growth
Key Trial Info
Start Date :
March 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
149 Patients enrolled
Trial Details
Trial ID
NCT04308902
Start Date
March 12 2020
End Date
December 1 2021
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hospital for Sick Children
Toronto, Ontario, Canada, M5G 0A4